Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 02, 2022

SELL
$0.23 - $0.46 $2,348 - $4,697
-10,212 Closed
0 $0
Q1 2022

Apr 20, 2022

SELL
$0.3 - $0.61 $17 - $35
-59 Reduced 0.57%
10,212 $4,000
Q4 2021

Jan 31, 2022

BUY
$0.55 - $1.04 $66 - $124
120 Added 1.18%
10,271 $6,000
Q3 2021

Nov 05, 2021

SELL
$1.06 - $1.52 $6 - $9
-6 Reduced 0.06%
10,151 $11,000
Q2 2021

Aug 12, 2021

BUY
$1.22 - $1.65 $12,391 - $16,759
10,157 New
10,157 $15,000

About iBio, Inc.


  • Ticker IBIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 9,006,580
  • Market Cap $24M
  • Description
  • iBio, Inc., a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. The company operates in two segments: Biopharmaceuticals and Bioprocessing. Its lead therapeutic candidate is IBIO-100 that is being advanced for investigational new drug development for t...
More about IBIO
Track This Portfolio

Track Xponance, Inc. Portfolio

Follow Xponance, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Xponance, Inc. with notifications on news.